Grade 2 Follicular Lymphoma — Trials

Grade 2 Follicular Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

182 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20
Recruiting: 7
Ph III recruiting: 0
Growth YoY: —
Industry share: 5%
Top sponsor: City of Hope Medical Center
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (42)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03185494	Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD22	unknown	Phase 1 / Phase 2	30	Chinese PLA General HospitalOTHER	1	Apr 17, 2019	clinicaltrials
NCT02685670	Competitive Transfer of αCD19-TCRz-CD28 and αCD19-TCRz-CD137 CAR-T Cells for B-cell Leukemia/Lymphoma(MatchCART)	unknown	Phase 1 / Phase 2	20	The Second Affiliated Hospital of Henan University of Traditional Chinese MedicineOTHER